Novex Innovations

Executive Summary

Novex Innovations is a US-based Contract Development and Manufacturing Organization (CDMO) founded in 2015 and headquartered in San Diego. The company specializes in providing end-to-end services to bridge the gap between research and commercialization for startups and small-to-medium enterprises in the drug delivery and medical device sectors. Operating through four divisions—Biologics & Tissue, Drug, Device, and Distribution—Novex offers a comprehensive suite of services including development, manufacturing, and supply chain support. Its focus on serving smaller innovators positions it as a critical partner in the life sciences ecosystem, particularly as large pharma continues to outsource more development work. With a strong foothold in the growing CDMO market, Novex Innovations is well-positioned to benefit from the increasing demand for specialized manufacturing capabilities. While the company remains privately held and lacks disclosed financials, its strategic location in San Diego's biotech hub and its multi-division approach provide diversified revenue streams. Key growth drivers include expansion of client contracts, potential facility upgrades, and partnerships with emerging biotechs. However, competition from larger CDMOs and reliance on a client base of startups introduces execution risk. Overall, Novex represents a promising but early-stage investment opportunity in the outsourced manufacturing space.

Upcoming Catalysts (preview)

• Q3 2026New contract wins with biotech startups70% success
• Q4 2026Completion of facility expansion to increase capacity60% success
• H1 2027Strategic partnership with a large pharmaceutical company40% success